Catalog No.
DHJ31099
Description
Sofituzumab vedotin is an ADC consisting of a MUC16-directed antibody and Monomethyl auristatin E (MMAE) used for the study of platinum-resistant ovarian cancer and unresectable pancreatic cancer.
Species reactivity
Human
Clonality
Monoclonal
Target
MUC16
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Purification
Purified by Ion Exchange Chromatography.
Applications
Research Grade Biosimilar
Form
Liquid
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
RG7458
Clone ID
Sofituzumab vedotin